Trial Profile
Comparison of the efficacy of Tadalafil, Tolterodine and Placebo in reduction of symptoms severity of women with Urgency, frequency syndrome/Overactive bladder
Status:
Active, no longer recruiting
Phase of Trial:
Phase III
Latest Information Update: 15 Sep 2016
Price :
$35
*
At a glance
- Drugs Tadalafil (Primary) ; Tolterodine
- Indications Overactive bladder; Urinary incontinence
- Focus Therapeutic Use
- 26 Jun 2013 New trial record
- 22 May 2013 Recruitment complete